Microarray analysis of aberrant microRNA expression patterns in spinal cord gliomas of different grades

An,Tian; Zhang,Xin-Qing; Liu,Yu-Fei; Lian,Juan; Wu,Yan-Xiang; Lv,Bo-Han; Liang,Cong; Chen,Chun-You; Yu,Qi-Shuai; Ma,Meng-Hua; Wang,Yin-Qian; Jiang,Guang-Jian; Fan,Tao

doi:10.3892/ol.2020.12234

Microarray analysis of aberrant microRNA expression patterns in spinal cord gliomas of different grades

Authors:
- Tian An
- Xin-Qing Zhang
- Yu-Fei Liu
- Juan Lian
- Yan-Xiang Wu
- Bo-Han Lv
- Cong Liang
- Chun-You Chen
- Qi-Shuai Yu
- Meng-Hua Ma
- Yin-Qian Wang
- Guang-Jian Jiang
- Tao Fan
View Affiliations

Affiliations: School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, P.R. China, Department of Neurosurgery, ChuiYangLiu Hospital Affiliated to Tsinghua University, Beijing 100022, P.R. China, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing 100029, P.R. China, Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing 100093, P.R. China, Department of Endocrinology, Workers Hospital of Tangshan City, Tangshan, Hebei 063000, P.R. China
Published online on: October 21, 2020 https://doi.org/10.3892/ol.2020.12234
Article Number: 371
Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

MicroRNAs (miRNAs) are involved in the development of several types of tumor; however, their role in spinal gliomas remains unknown. The present study aimed to identify potentially novel spinal cord gliomas (SCG)‑associated miRNAs and to characterize their roles in the development and progression of SCG. miRNA expression levels in low‑grade SCG (classed as stage I‑II SCG based on the World Health Organization grading system), high‑grade SCG (classed as stage IV SCG based on the World Health Organization grading system) and 5 control cases were measured using a miRNA expression microarray. Subsequently, blood samples from the spinal cord of patients with differing grades of SCG were screened for differentially expressed miRNAs (DEmiRNAs). Compared with the control group, 7 upregulated and 36 downregulated miRNAs were identified in the low‑grade SCG group and a total of 70 upregulated and 20 downregulated miRNAs were identified in the high‑grade SCG group (P≤0.05, fold change >2). Gene Ontology analysis revealed that the regulation of cellular metabolic processes, negative regulation of biological processes and axon guidance were primarily involved. Moreover, pathway analysis showed that the target genes of DEmiRNAs were enriched in tumor‑related signaling pathways, such as the MAPK and Wnt signaling pathway. The results suggest that DEmiRNAs in peripheral blood may serve as novel target markers with high specificity and sensitivity for the diagnosis of SCG.

View Figures

View References

1	Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P and Ellison DW: The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
2	Appin CL and Brat DJ: Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis. Adv Anat Pathol. 22:50–58. 2015. View Article : Google Scholar : PubMed/NCBI
3	Tanaka S, Louis DN, Curry WT, Batchelor TT and Dietrich J: Diagnostic and therapeutic avenues for glioblastoma: No longer a dead end? Nat Rev Clin Oncol. 10:142013. View Article : Google Scholar : PubMed/NCBI
4	Kalpathy-Cramer J, Gerstner ER, Emblem KE, Andronesi O and Rosen B: Advanced magnetic resonance imaging of the physical processes in human glioblastoma. Cancer Res. 74:4622–4637. 2014. View Article : Google Scholar : PubMed/NCBI
5	Dlouhá D and Hubáček JA: Regulatory RNAs and cardiovascular disease-with a special focus on circulating microRNAs. Physiol Res. 66 (Suppl 1):S21–S38. 2017. View Article : Google Scholar : PubMed/NCBI
6	Gregory RI and Shiekhattar R: MicroRNA biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
7	Xu HS, Zong HL, Shang M, Ming X, Zhao JP, Ma C and Cao L: MiR-324-5p inhibits proliferation of glioma by target regulation of GLI1. Eur Rev Med Pharmacol Sci. 18:828–832. 2014.PubMed/NCBI
8	Duan R, Han L, Wang Q, Wei J, Chen L, Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
9	Cui R, Guan Y, Sun C, Chen L, Bao Y, Li G, Qiu B, Meng X, Pang C and Wang Y: A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma. Cancer Lett. 374:1–11. 2016. View Article : Google Scholar : PubMed/NCBI
10	Gu Y, Zhang Z, Yin J, Ye J, Song Y, Liu H, Xiong Y, Lu M, Zheng G and He Z: Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1). J Exp Clin Cancer Res. 36:1142017. View Article : Google Scholar : PubMed/NCBI
11	Mo FF, An T, Zhang ZJ, Liu YF, Liu HX, Pan YY, Miao JN, Zhao DD, Yang XY, Zhang DW, et al: Jiang Tang Xiao Ke Granule Play an anti-diabetic role in diabetic mice pancreatic tissue by regulating the mRNAs and MicroRNAs associated with PI3K-Akt signaling pathway. Front Pharmacol. 8:7952017. View Article : Google Scholar : PubMed/NCBI
12	Milano MT, Johnson MD, Sul J, Mohile NA, Korones DN, Okunieff P and Walter KA: Primary spinal cord glioma: A surveillance, epidemiology, and end results database study. J Neurooncol. 98:83–92. 2010. View Article : Google Scholar : PubMed/NCBI
13	Jansen M, Yip S and Louis DN: Molecular pathology in adult gliomas: Diagnostic, prognostic, and predictive markers. Lancet Neurol. 9:717–726. 2010. View Article : Google Scholar : PubMed/NCBI
14	Riddick G and Fine HA: Integration and analysis of genome-scale data from gliomas. Nat Rev Neurol. 7:439–450. 2011. View Article : Google Scholar : PubMed/NCBI
15	Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M and Greenberg ME: A brain-specific microRNA regulates dendritic spine development. Nature. 439:283–289. 2006. View Article : Google Scholar : PubMed/NCBI
16	Davis-Dusenbery BN and Hata A: MicroRNA in cancer: The involvement of aberrant MicroRNA biogenesis regulatory pathways. Genes Cancer. 1:1100–1114. 2010. View Article : Google Scholar : PubMed/NCBI
17	Molina-Pinelo S, Suárez R, Pastor MD, Nogal A, Márquez-Martín E, Martín-Juan J, Carnero A and Paz-Ares L: Association between the miRNA signatures in plasma and bronchoalveolar fluid in respiratory pathologies. Dis Markers. 32:221–230. 2012. View Article : Google Scholar : PubMed/NCBI
18	Sud N, Zhang H, Pan K, Cheng X, Cui J and Su Q: Aberrant expression of microRNA induced by high-fructose diet: Implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance. J Nutr Biochem. 43:125–131. 2017. View Article : Google Scholar : PubMed/NCBI
19	Jiang G, Ma Y, An T, Pan Y, Mo F, Zhao D, Liu Y, Miao JN, Gu YJ, Wang Y and Gao SH: Relationships of circular RNA with diabetes and depression. Sci Rep. 7:72852017. View Article : Google Scholar : PubMed/NCBI
20	Wang K, Wang X, Zou J, Zhang A, Wan Y, Pu P, Song Z, Qian C, Chen Y, Yang S and Wang Y: miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol. 15:578–588. 2013. View Article : Google Scholar : PubMed/NCBI
21	Zhang H, Qi Y, Geng D, Shi Y, Wang X, Yu R and Zhou X: Expression profile and clinical significance of Wnt signaling in human gliomas. Oncol Lett. 15:6102018.PubMed/NCBI
22	Guo G, Yao W, Zhang Q and Bo Y: Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013. View Article : Google Scholar : PubMed/NCBI
23	Dong L, Qi N, Ge RM, Cao CL, Lan F and Shen L: Overexpression of CD133 promotes the phosphorylation of Erk in U87MG human glioblastoma cells. Neurosci Lett. 484:210–214. 2010. View Article : Google Scholar : PubMed/NCBI
24	Wang BQ, Yang B, Yang HC, Wang JY, Hu S, Gao YS and Bu XY: MicroRNA-499a decelerates glioma cell proliferation while accelerating apoptosis through the suppression of Notch1 and the MAPK signaling pathway. Brain Res Bull. 142:96–106. 2018. View Article : Google Scholar : PubMed/NCBI
25	Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y and Zhi F: Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. Onco Targets Ther. 11:1183–1192. 2018. View Article : Google Scholar : PubMed/NCBI
26	Ishibe Y, Kusaoi M, Murayama G, Nemoto T, Kon T, Ogasawara M, Kempe K, Yamaji K and Tamura N: Changes in the expression of circulating microRNAs in systemic lupus erythematosus patient blood plasma after passing through a plasma adsorption membrane. Ther Apher Dial. 22:278–289. 2018. View Article : Google Scholar : PubMed/NCBI
27	Mo LJ, Song M, Huang QH, Guan H, Liu XD, Xie DF, Huang B, Huang RX and Zhou PK: Exosome-packaged miR-1246 contributes to bystander DNA damage by targeting LIG4. Br J Cancer. 119:492–502. 2018. View Article : Google Scholar : PubMed/NCBI
28	Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, et al: Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 9:15350–15364. 2018. View Article : Google Scholar : PubMed/NCBI
29	Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H and Tian Y: Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma. Cancer Med. 7:1670–1679. 2018. View Article : Google Scholar : PubMed/NCBI
30	Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y and Saini S: MicroRNA-1246 is an exosomal biomarker for aggressive prostate cancer. Cancer Res. 78:1833–1844. 2018. View Article : Google Scholar : PubMed/NCBI
31	Li XJ, Ren ZJ, Tang JH and Yu Q: Exosomal MicroRNA MiR-1246 promotes cell proliferation, invasion and drug resistance by targeting CCNG2 in breast cancer. Cell Physiol Biochem. 44:1741–1748. 2017. View Article : Google Scholar : PubMed/NCBI
32	Chen SM, Chen HC, Chen SJ, Huang CY, Chen PY, Wu TW, Feng LY, Tsai HC, Lui TN, Hsueh C and Wei KC: MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6. World J Surg Oncol. 11:872013. View Article : Google Scholar : PubMed/NCBI